Evidence map›Paper›PMID 29907423›Full record

ReviewAlzheimer's & dementia : the journal of the Alzheimer's Association2018

Understanding the impact of sex and gender in Alzheimer's disease: A call to action.

Rebecca A Nebel, Neelum T Aggarwal, Lisa L Barnes, Aimee Gallagher, Jill M Goldstein, Kejal Kantarci, Monica P Mallampalli, Elizabeth C Mormino, Laura Scott, Wai Haung Yu and 2 more

Open access · greenAbstract readReview
In one paragraph

Review in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 484 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
484citing papers in PubMed, 6 pooled it
38.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

484 citing papers in PubMed, 6 syntheses or guidelines pooled it, 816 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Sex differences inFrontiers in dementia · 2025
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Review
  13. Review
  14. Article
  15. Article
  16. Tau-PET and CSF MTBR-tau243 comparisons validate increased tau aggregation in females.European journal of nuclear medicine and molecular imaging · 2026
    Article
  17. Refining our understanding of sleep impairment and connection to Alzheimer's disease in preclinical models.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  18. Article
  19. The Neurology of Menopause.Current neurology and neuroscience reports · 2026
    Review
  20. Article

424 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 1 country.

Rebecca A NebelScientific Programs, Society for Women's Health Research (SWHR®), Washington, DC, USA. Electronic address: rebecca@swhr.org.
Neelum T AggarwalDepartment of Neurological Sciences and the Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.
Lisa L BarnesDepartment of Neurological Sciences and the Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.
Aimee GallagherScientific Programs, Society for Women's Health Research (SWHR®), Washington, DC, USA.
Jill M GoldsteinDepartment of Psychiatry, Harvard Medical School, and Massachusetts General Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, and Massachusetts General Hospital, Boston, MA, USA.
Kejal KantarciDepartment of Radiology, Mayo Clinic, Rochester, MN, USA.
Monica P MallampalliScientific Programs, Society for Women's Health Research (SWHR®), Washington, DC, USA.
Elizabeth C MorminoDepartment of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.
Laura ScottCellular and Molecular Medicine Program, Johns Hopkins University, Baltimore, MD, USA.
Wai Haung YuDepartment of Pathology and Cell Biology, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, NY, USA.
Pauline M MakiDepartment of Psychology, University of Illinois at Chicago, Chicago, IL, USA; Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, USA.
Michelle M MielkeDepartment of Epidemiology, Mayo Clinic, Rochester, MN, USA; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Society for Women's Health Research · USRush University Medical Center · USColumbia University · USJohns Hopkins University · USMassachusetts General Hospital · USMayo Clinic · USMayo Clinic in Arizona · USStanford University · USUniversity of Illinois Chicago · US

Funding

THE PGRN/TDP-43 AXIS IN ALZHEIMER?S DISEASE AND NEURODEGENERATIONP50AG016574 · NIA · MAYO CLINIC ROCHESTER · PI PETERSEN, RONALD C · 1999 to 2018
$36.9M
Prevention of Alzheimer's disease in women: risks and benefits of hormone therapyRF1AG057547 · NIA · MAYO CLINIC ROCHESTER · PI GLEASON, CAREY E, KANTARCI, KEJAL · 2017 to 2020
$11.1M
NIA NIH HHS P50 AG016574NIA NIH HHS RF1 AG057547
6 · The paper itself

Abstract

introductionPrecision medicine methodologies and approaches have advanced our understanding of the clinical presentation, development, progression, and management of Alzheimer's disease (AD) dementia. However, sex and gender have not yet been adequately integrated into many of these approaches.

methodsThe Society for Women's Health Research Interdisciplinary Network on AD, comprised of an expert panel of scientists and clinicians, reviewed ongoing and published research related to sex and gender differences in AD.

resultsThe current review is a result of this Network's efforts and aims to: (1) highlight the current state-of-the-science in the AD field on sex and gender differences; (2) address knowledge gaps in assessing sex and gender differences; and (3) discuss 12 priority areas that merit further research. DISCUSSION: The exclusion of sex and gender has impeded faster advancement in the detection, treatment, and care of AD across the clinical spectrum. Greater attention to these differences will improve outcomes for both sexes.

Indexed as

Alzheimer DiseaseGender IdentitySex CharacteristicsAnimalsHumansAlzheimer's diseaseBiomarkersEpidemiologyGenderHormonesMenMenopauseMild cognitive impairmentRisk factorsSexWomen

Identifiers

PMID29907423
PMCPMC6400070
OpenAlexW2808227793

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.